Lanisidenib
Lanisidenib is the inhibitor for isocitrate dehydrogenase that exhibits antineoplastic activity[1].
Product Specifications
CAS Number
2135537-20-9
UNSPSC
12352211
Target
Isocitrate Dehydrogenase (IDH)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC(F)(C1)CC1NC([C@H](C2=C(C=CC=C2)Cl)N(C3=CC(F)=CC=C3)C([C@H]4N(C5=CC(C#N)=CC=N5)S(=O)(CC4)=O)=O)=O
Molecular Formula
C28H23ClF3N5O4S
Molecular Weight
618.03
References & Citations
[1]WHO-Volume38 Number4 2024
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
043200-AP 200 µL
TREF1, CT (TRERF1, BCAR2, RAPA, TREP132, Transcriptional-regulating factor 1, Breast cancer anti-estrogen resistance 2, Transcriptional-regulating protein 132, Zinc finger protein rapa, Zinc finger transcription factor TReP-132) (AP) discontinued
Sign In for Pricing
View Details 
585328-01 20 µg
Mast Cell Protease 1, Recombinant, Rat, aa21-260, Myc-Tag
Sign In for Pricing
View Details 585328-02 200 µg
Mast Cell Protease 1, Recombinant, Rat, aa21-260, Myc-Tag
Sign In for Pricing
View Details